Report Overview

The Global sinus dilation device market Market size is expected to be worth around USD 6.96 billion by 2032 from USD 3 billion in 2023, growing at a CAGR of 10.60% during the forecast period from 2023 to 2032.

The market’s growth has been fueled by the increasing popularity of minimally invasive procedures, greater awareness about the pros and cons of balloon sinuplasty, favorable reimbursement situations, as well as chronic sinusitis.

 

Global Sinus Dilation Device Market Scope:

Product Analysis

In terms of ‘Product’, the largest revenue share of more than 46.3%, was accounted for by the ‘Balloon Sinus Dilation Devices’ segment in 2021. BSDs are small, flexible, safe, and highly effective in relieving sinusitis symptoms. Sinus dilation is a non-invasive procedure that does not require tissue ablation. This market for sinus Dilation Devices reports allows for quick turnaround and improved patient comfort. BSD procedures may need to be repeated as they are temporary.

The ‘Functional Endoscopic Sinus Surgery Instruments Set’ segment is projected to experience the fastest annual growth rate, at more than 13.6%, over the forecast period. It’s used to treat chronic and recurrent acute rhino sinusitis, as well as medically refractory persistent rhino sinusitis. It is minimally invasive, and it is preferred over other procedures. This market scenario is expected to boost segment growth in the foreseeable future.

Procedure Analysis

With respect to ‘Procedure’, the ‘Standalone Procedure’ segment accounted for the highest revenue share, at 67.3%, in 2021. Balloon sinus ostial dilation can be done as a stand-alone procedure. A standalone balloon dilation procedure is just as effective for chronic rhino sinusitis treatment as functional endoscopic surgery. This Sinus Dilation Devices market’s major share segment is also expected to expand owing to the increasing preference for minimally invasive procedures as a result of greater use and their acceptance by healthcare insurance.

Balloon Sinus Ostial Dilation can be performed with functional sinus surgery. This procedure is known as a “hybrid” because it combines elements of both balloon and functional sinus surgery. A hybrid functional endoscopic balloon dilation procedure for pediatric and adult patients is possible. This market trend is expected to grow due to the increasing popularity of hybrid procedures for both children and adults.

End Use Analysis

On the basis of ‘End-Use’, the ‘Hospitals’ segment accounted for the highest revenue market opportunity at over 50.2% in 2021. It is expected that hospitals will register substantial growth over the forecast period due to the high number of procedures being performed in hospitals. Segment growth will be bolstered by the increasing prevalence of chronic sinusitis and favorable reimbursement criteria. Segment growth will also be complemented by improved infrastructure and medical equipment, as well as a greater ability to perform complex sinus surgeries.

The fastest CAGR is expected to be indexed by the ‘Ambulatory Surgical Centers’ segment over the forecast period. ASCs are a strategic option for providing surgical services. ASCs allow for minimally invasive procedures like BSD. This segment’s growth is expected to be driven by cost-effectiveness, as well as better reimbursement options than hospitals.

Application Analysis

Owing to the high prevalence of sinusitis among adults, the ‘Adult Patient’ segment accounted for 67.4% of total revenues in 2021. For instance, in September 2017, sinusitis was found to be more prevalent in adults than in children according to the CDC. In the United States, 9 out of 10 sinusitis cases were caused by viral sinusitis reported in adults.

The ‘Pediatric’ segment is expected to index the highest CAGR over the forecast period. The rise in sinusitis among children can be attributed to this growth. According to the National Center for Biotechnology Information in the U.S. in 2015, 6-13% of children in the country developed chronic rhino sinusitis. Several key market players have begun to develop key product segments for pediatric patients in an effort to retain their respective market position.

Key Market Segments:

Product

• Balloon Sinus Dilation Devices
• Functional Endoscopic Sinus Surgery (FESS) Instruments Set
• Endoscopes
• Sinus Stents/Implants
• Others

Procedure

• Hybrid
• Standalone

Application

• Pediatric
• Adult

End-use

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• ENT Clinics/In-office

Market Dynamics

Market dynamics are expected to be boosted by the development of new techniques for surgery, which are replacing older procedures. In sinus surgery, technological advancements such as laser technologies ensure minimal ablation with fewer side effects. These procedures can now be performed as outpatient treatment.

Interruptions in routine patient services were caused by the onset of the COVID-19 pandemic. Many governments on healthcare organization providers have stopped routine clinic visits and elective procedures to increase and preserve the availability of in-patient beds. In addition, they have reorganized medical staff and nursing staff. Patients with chronic rhinitis are particularly affected by this market research study. Patients opted for teleconsultations, and temporarily for sinus-related disorders.

COVID-19 vaccines will normalize elective surgery, which is good news for this market size. Major players in this market for sinus Dilation devices report include Smith & Nephew, Smith & Nephew, Medtronic, as well as Acclarent Inc. These key players are focusing their efforts on mergers & acquisitions, as well as higher investments towards the development of technological advancements and R&D initiatives to expand their geographical reach. Smith & Nephew spent US$222 million in FY2015, and US$223 million in 2017 on research & development.

Regional Analysis

North America accounted for the largest market share, at 38.8% in 2021. This dominance is expected to continue over the forecast period. This market research study is due to the country’s highly regulated and well-developed healthcare infrastructure. Demand for Sinus Dilation Devices Market growth is being driven by the availability and quality of innovative product types, which is made possible by major factor market players. The Asia Pacific is expected to index the fastest annual growth rate over the forecast period, due to an increase in disposable incomes as well as greater patient awareness concerning sinus surgery.

Olympus Corporation and InnAccel Technologies are looking to make acquisitions and expand their product approval range in order to deliver high-quality products in emerging markets for Sinus Dilation Devices. Olympus Corp. signed a definitive contract for US$ 87 million in April 2017 to acquire Image Stream Medical Inc. to provide better medical solution assistance to healthcare spending facilities.

Key Regions and Countries Covered іn This Rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share Analysis

This market growth is highly concentrated with a small number of established key companies controlling the majority stake. key market players have employed a number of key factors and business strategies to maintain their respective market major share while expanding their geographic reach. These market reports include product type launches, advanced product approvals, as well as strategic acquisitions and innovations. Stryker Corp. bought Entellus Medical, a U.S. company that provides minimally invasive ENT services in the U.S., in December 2017.

To cater to the growing need for minimally invasive ENT procedures, Entellus Medical has introduced the Latera Absorbable Nasal Implant, MiniFESS Surgical Tools, XprESS ENT Dissection System, and FocESS Imaging & Navigation Devices.

Key Market Players

Market major companies in the global sinus dilation device industry include:

• Smith & Nephew
• Stryker
• Medtronic
• Olympus Corporation
• Acclarent
• Entellus Medical
• SinuSys Corporation
• Intersect ENT Inc.
• Olympus Corporation
• Other Key Players